Kindly MD, Inc. Files 8-K Under 'Other Events'
Ticker: NAKAW · Form: 8-K · Filed: Aug 28, 2025 · CIK: 1946573
| Field | Detail |
|---|---|
| Company | Kindly Md, Inc. (NAKAW) |
| Form Type | 8-K |
| Filed Date | Aug 28, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $0.0001, $5,000,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure
TL;DR
Kindly MD filed a standard 8-K, nothing major to see here.
AI Summary
Kindly MD, Inc. filed an 8-K on August 28, 2025, reporting an event that occurred on August 26, 2025. The filing is categorized under 'Other Events' and does not specify any material changes or agreements.
Why It Matters
This 8-K filing indicates a routine disclosure by Kindly MD, Inc. without immediate apparent material impact on the company's operations or stock.
Risk Assessment
Risk Level: low — The filing is a routine 8-K under 'Other Events' and does not disclose any significant new information, acquisitions, or financial changes.
Key Players & Entities
- Kindly MD, Inc. (company) — Registrant
- August 26, 2025 (date) — Earliest event date
- August 28, 2025 (date) — Filing date
- 001-42103 (company) — SEC File Number
- 84-3829824 (company) — IRS Employer Identification Number
FAQ
What is the specific nature of the event reported under 'Other Events'?
The filing does not specify the nature of the event, only that it falls under the 'Other Events' category.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on August 26, 2025.
What is the SEC file number for Kindly MD, Inc.?
The SEC file number for Kindly MD, Inc. is 001-42103.
What is the principal executive office address for Kindly MD, Inc.?
The principal executive office is located at 5097 South 900 East, Suite 100, Salt Lake City, UT 84117.
What is the IRS Employer Identification Number for Kindly MD, Inc.?
The IRS Employer Identification Number for Kindly MD, Inc. is 84-3829824.
Filing Stats: 810 words · 3 min read · ~3 pages · Grade level 12.9 · Accepted 2025-08-27 17:48:11
Key Financial Figures
- $0.001 — ch Registered Common Stock, par value $0.001 NAKA The Nasdaq Stock Market LLC
- $0.0001 — hares ") of its common stock, par value $0.0001 per share (the " Company Common Stock "
- $5,000,000,000 — aving an aggregate sales price of up to $5,000,000,000 (the " ATM Offering "). Subject to the
Filing Documents
- ea0254796-8k_kindly.htm (8-K) — 30KB
- 0001213900-25-081238.txt ( ) — 236KB
- naka-20250826.xsd (EX-101.SCH) — 4KB
- naka-20250826_def.xml (EX-101.DEF) — 26KB
- naka-20250826_lab.xml (EX-101.LAB) — 36KB
- naka-20250826_pre.xml (EX-101.PRE) — 25KB
- ea0254796-8k_kindly_htm.xml (XML) — 6KB
01 Other Events
Item 8.01 Other Events. On August 26, 2025, Kindly MD, Inc. (the " Company ") entered into a Sales Agreement (the " Sales Agreement ") with TD Securities (USA) LLC, Cantor Fitzgerald & Co., B. Riley Securities, Inc., The Benchmark Company, LLC, Canaccord Genuity LLC, Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, Craig-Hallum Capital Group LLC, Needham & Company, LLC and Yorkville Securities, LLC (each, an " Agent " and together, the " Agents "), pursuant to which the Company from time to time, at its option, may offer and sell shares (the " Shares ") of its common stock, par value $0.0001 per share (the " Company Common Stock "), through the Agents, having an aggregate sales price of up to $5,000,000,000 (the " ATM Offering "). Sales Agreement, the Agents will use commercially reasonable efforts consistent with their normal trading and sales practices to sell the Shares from time to time, based upon the Company's instructions. The Company has provided the Agents with customary indemnification and contribution rights in favor of the Agents, and the Agents will be entitled to a commission of up to 2.0% of the gross proceeds from each sale of the Shares pursuant to the Sales Agreement. Upon delivery of a placement notice, and subject to the terms and conditions of the Sales Agreement, the Agents may sell the Shares by methods deemed to be an "at the market offering" as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended. The Company may sell the Shares through the Agents in amounts and at times to be determined by the Company from time to time subject to the terms and conditions of the Sales Agreement, but it has no obligation to sell any of the Shares in the Offering. The Company will only sell Shares through one Agent on any single day. The description of the Sales Agreement does not purport to be complete and is qualified in its entirety by reference to
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunder duly authorized. KINDLY MD, INC. Dated: August 27, 2025 By : /s/ David Bailey David Bailey Chief Executive Officer 2